Advertisement

Topics

Optimal Use With Adjuvant Endocrine Therapy Continues to Unfold in ER+ Breast Cancer

13:13 EDT 9 Jul 2018 | OncLive

Alex E. Denes, MD, discusses the mixed results looking at the optimal duration of adjuvant endocrine therapy in postmenopausal women with breast cancer.

Original Article: Optimal Use With Adjuvant Endocrine Therapy Continues to Unfold in ER+ Breast Cancer

NEXT ARTICLE

More From BioPortfolio on "Optimal Use With Adjuvant Endocrine Therapy Continues to Unfold in ER+ Breast Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pancreatitis
Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake.  Diagnosis is based on clinical presentation...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...